Total Payments
$2,089
2023 Payments
$111.50
Companies
25
Transactions
91
Medicare Patients
1,761
Medicare Billing
$210,317
Payment Breakdown by Category
Food & Beverage$1,859 (89.0%)
Education$230.53 (11.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,859 | 85 | 89.0% |
| Education | $230.53 | 6 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $265.82 | 7 | $0 (2023) |
| Janssen Biotech, Inc. | $254.90 | 15 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $218.80 | 21 | $0 (2020) |
| Astellas Pharma US Inc | $157.13 | 5 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $124.15 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $117.25 | 1 | $0 (2017) |
| Janssen Products, LP | $114.98 | 2 | $0 (2017) |
| ViiV Healthcare Company | $102.39 | 7 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $95.52 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.84 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $111.50 | 2 | Insmed, Inc. ($76.95) |
| 2022 | $15.20 | 1 | GlaxoSmithKline, LLC. ($15.20) |
| 2021 | $251.07 | 3 | Insmed, Inc. ($126.92) |
| 2020 | $49.27 | 3 | Merck Sharp & Dohme Corporation ($19.77) |
| 2019 | $278.74 | 16 | Melinta Therapeutics, Inc. ($67.64) |
| 2018 | $757.18 | 37 | Janssen Biotech, Inc. ($139.50) |
| 2017 | $626.12 | 29 | Teva Pharmaceuticals USA, Inc. ($117.25) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $76.95 | General |
| Category: Respiratory | ||||||
| 07/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.55 | General |
| 02/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $124.15 | General |
| Category: Cardiology | ||||||
| 11/04/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $120.97 | General |
| Category: Respiratory | ||||||
| 03/03/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $5.95 | General |
| Category: Respiratory | ||||||
| 02/11/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/28/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Respiratory | ||||||
| 01/07/2020 | TETRAPHASE PHARMACEUTICALS, INC. | XERAVA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 12/04/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug), Orbactiv | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: ANTIBIOTICS | ||||||
| 11/26/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 11/14/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Education | In-kind items and services | $12.70 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/10/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 09/11/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Respiratory | ||||||
| 05/30/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/29/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: VACCINES | ||||||
| 05/20/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Respiratory | ||||||
| 05/15/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: ANTIBIOTICS | ||||||
| 05/13/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/07/2019 | Theratechnologies Inc. | TROGARZO (Drug), EGRIFTA | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: HIV | ||||||
| 05/06/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 01/22/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/17/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DIFICID | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 167 | 366 | $91,104 | $23,118 |
| 2022 | 3 | 378 | 709 | $121,499 | $40,443 |
| 2021 | 4 | 659 | 1,445 | $232,230 | $77,649 |
| 2020 | 4 | 557 | 1,276 | $201,334 | $69,106 |
Total Patients
1,761
Total Services
3,796
Medicare Billing
$210,317
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 220 | $50,600 | $13,471 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 65 | $27,625 | $6,540 | 23.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 81 | $12,879 | $3,107 | 24.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 154 | 164 | $50,676 | $16,965 | 33.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 122 | 288 | $44,352 | $15,880 | 35.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 102 | 257 | $26,471 | $7,598 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 194 | 493 | $75,922 | $27,134 | 35.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 238 | 260 | $80,340 | $26,942 | 33.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 195 | 611 | $62,933 | $17,898 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 81 | $13,035 | $5,676 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 179 | 450 | $69,300 | $25,317 | 36.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 198 | 218 | $67,362 | $23,636 | 35.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 151 | 544 | $56,032 | $16,595 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 64 | $8,640 | $3,558 | 41.2% |
About Dr. Natalie Cauthen, MD
Dr. Natalie Cauthen, MD is a Infectious Disease healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124095658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Natalie Cauthen, MD has received a total of $2,089 in payments from pharmaceutical and medical device companies, with $111.50 received in 2023. These payments were reported across 91 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,859).
As a Medicare-enrolled provider, Cauthen has provided services to 1,761 Medicare beneficiaries, totaling 3,796 services with total Medicare billing of $210,317. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location West Columbia, SC
- Active Since 03/03/2006
- Last Updated 10/15/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1124095658
Products in Payments
- PREZCOBIX (Drug) $328.31
- Arikayce (Drug) $265.82
- UPTRAVI (Drug) $124.15
- CINQAIR (Drug) $117.25
- FASENRA (Drug) $95.52
- ZERBAXA (Drug) $85.63
- TRIUMEQ (Drug) $69.53
- ISENTRESS (Drug) $59.61
- Mavyret (Drug) $55.22
- CRESEMBA (Drug) $49.08
- Daraprim Tablet 25mg (Drug) $46.47
- Symtuza (Drug) $41.57
- EGRIFTA (Drug) $36.85
- Vabomere (Drug) $33.98
- Orbactiv (Drug) $33.66
- Aristada 441 mg (Drug) $32.24
- Xerava (Drug) $30.13
- ABILIFY MAINTENA (Drug) $26.19
- ZOSTAVAX (Biological) $24.17
- BIOPATCH (Device) $21.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in West Columbia
Emilio Perez-Jorge, Md, MD
Infectious Disease — Payments: $4,057
Infectious Disease $4,057
Elizabeth Nimmich, M.d, M.D
Infectious Disease — Payments: $2,929
Infectious Disease $2,929
Samantha Williams, Md, MD
Infectious Disease — Payments: $628.39
Infectious Disease $628.39
Rebecca Berdel, Md, MD
Infectious Disease — Payments: $405.96
Infectious Disease $405.96